Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amgen
Amgen
Earnings Preview: Amgen to report 4Q results
Yahoo/AP
Fri, 01/22/10 - 10:47 am
Amgen
earnings
Digging Deeper into Adventrx Pharmaceuticals
TheStreet.com
Tue, 01/19/10 - 09:40 am
Adventrx
Genentech
Novartis
Amgen
Pfizer
Novelos Therapeutics
ONYX Pharmaceuticals
J&J Has Success with Psoriasis Treatment
Seeking Alpha
Tue, 01/19/10 - 09:25 am
psoriasis
JNJ
Amgen
Abbott Laboratories
Enbrel
Humira
Stelara
The Future of Biotech: Party Like It's 1999
Seeking Alpha
Mon, 01/18/10 - 12:40 pm
Amgen
Genzyme
Biogen Idec
Celgene
Gilead Sciences
Teva Pharmaceuticals
Watson Pharmaceuticals
OSI Pharmaceuticals
Sunesis
Amag Pharmaceuticals
Jazz Pharmaceuticals
Indenix
Inspire
Novavax
Cyclacel
Cardica
Micromet
Rosetta Genomics
3 Different Scenarios for Glaxosmithkline's Sirtris Investment
Seeking Alpha
Mon, 01/18/10 - 11:51 am
GSK
Sirtris
Pfizer
Amgen
Amgen Cancer Push on Bone Drug May Key Stock Turnaround in 2010
Bloomberg
Thu, 01/14/10 - 09:00 am
Amgen
denosumab
Amgen as a Short Candidate
Seeking Alpha
Wed, 01/13/10 - 09:23 am
Amgen
Johnson & Johnson: My First Pick of 2010
Seeking Alpha
Mon, 01/11/10 - 11:27 am
JNJ
Eli Lilly
Novartis
Amgen
Proctor & Gamble
Biogen Idec
Genzyme
Gilead Sciences
Teva Pharmaceuticals
King
Mylan
Pfizer
GSK
Sanofi
Abbott Laboratories
Former Amgen Rep Stymied By Arbitration
Pharmalot
Mon, 01/11/10 - 11:00 am
Amgen
sales reps
lawsuits
off-label
Despite FDA Recommendation for Postmarketing Surveillance, Amgen's Prolia Will Achieve Blockbuster Sales for Treatment of Osteoporosis
Trading Markets
Sat, 01/9/10 - 12:49 pm
Prolia
osteoporosis
Amgen
Amgen’s, J&J’s Anemia Drugs Face FDA Advisory Review on Dose
Bloomberg
Thu, 01/7/10 - 09:53 am
FDA
anemia
Amgen
Aranesp
Epogen
Procrit
JNJ
Biotech drug approvals spiked in 2009
Fierce Biotech
Wed, 01/6/10 - 08:45 am
biotech
Eli Lilly
Effient
Daiichi Sankyo
denosumab
Amgen
Aventis
Multaq
Biotech's Movers and Shakers 2009: BioBuzz
TheStreet.com
Mon, 01/4/10 - 09:38 am
Biogen Idec
Genzyme
Amgen
Gilead Sciences
Celgene
Vanda
Human Genome Sciences
Keryx
Opexa
CompuGen
Repros Therapeutics
Sequenom
GTx
GTC Biotherapeutics
Amgen, others may benefit from reform-Barron's
Reuters
Mon, 01/4/10 - 09:29 am
healthcare reform
Amgen
Alexion
Large-Cap Biotechs Face Familiar Problem
Yahoo/Investors Business Daily
Mon, 12/28/09 - 04:47 am
biotech
Amgen
Biogen Idec
Bristol-Myers Squibb
Roche
Genzyme
Gilead Sciences
Celgene
2009 Biotech Cheers and Jeers
Motley Fool
Wed, 12/23/09 - 08:45 am
Human Genome Sciences
GSK
Vanda
Sequenom
Genzyme
Amgen
Merck
Eli Lilly
It’s Official: Roche Infringed On Amgen Patents
Pharmalot
Wed, 12/23/09 - 08:28 am
Amgen
Roche
patents
anemia
Mircera
Amgen Closer to Prolia Approval
Yahoo/Zacks.com
Mon, 12/21/09 - 05:22 pm
Amgen
Prolia
Amgen's D-mab one step closer to EU approval
Fierce Biotech
Fri, 12/18/09 - 11:16 am
Europe
Amgen
denosumab
Five Biotech Events to Watch in 2010
TheStreet.com
Wed, 12/16/09 - 11:22 am
biotech
Medivation
Elan
Pfizer
Dendreon
Vertex Pharmaceuticals
Amgen
InterMune
Pages
« first
‹ previous
…
99
100
101
102
103
104
105
106
107
…
next ›
last »